natgillin/translations-raw huggingface dataset:
However, post-marketing, a few isolated cases of elevated INR of clinical significance have been reported during concomitant treatment. 
Po prihodu zdravila na trg pa so med takšnim sočasnim zdravljenjem ugotovili nekaj posameznih primerov klinično pomembnega zvišanja INR.
Inconsistent data on the clinical implications of this PK/PD interaction in terms of major cardiovascular events have been reported from both observational and clinical studies. 
Opazovalne in klinične študije so dale neskladne podatke o kliničnih posledicah tega farmakokinetičnega/farmakodinamičnega medsebojnega delovanja, kar zadeva pomembne kardiovaskularne dogodke.
Nexium Control has a low likelihood of affecting your ability to drive or use machines. 
Malo je verjetno, da bi zdravilo Nexium Control vplivalo na sposobnost upravljanja vozil in strojev.
What Nexium Control looks like and contents of the pack Nexium Control 20 mg gastro-resistant hard capsules are approximately 11 x 5 mm capsules with a clear body, and an amethyst cap imprinted with “NEXIUM 20 MG” in white. 
Izgled zdravila Nexium Control in vsebina pakiranja Zdravilo Nexium Control 20 mg kapsule so trde gastrorezistentne kapsule, velike približno 11 x 5 mm, s prozornim telesom in pokrovčkom vijolične barve z natisnjeno oznako "NEXIUM 20MG" v beli barvi.
Nexium Control contains the active substance esomeprazole. 
Zdravilo Nexium Control vsebuje učinkovino esomeprazol.
• Erlotinib (used to treat cancer) 
• erlotinib (uporablja se za zdravljenje raka)
Single doses of 80 mg esomeprazole were uneventful. 
Enkratni odmerki 80 mg esomeprazola niso povzročili simptomov.
You may need to take the tablets for 2-3 days in a row before you feel better. 
Morda boste morali tablete jemati 2 ali 3 dni zapored, preden se boste počutili bolje.
Respiratory, thoracic and mediastinal disorders bronchospasm 
Bolezni dihal, prsnega koša in mediastinalnega prostora bronhospazem
Capsule approximately 11 x 5 mm, with a clear body, and an amethyst cap imprinted with “NEXIUM 20 MG” in white. 
Kapsula, velika približno 11 x 5 mm, s prozornim telesom in pokrovčkom vijolične barve z natisnjeno oznako ''NEXIUM 20 MG'' v beli barvi.
Yellow iron oxide (E172) 
Črta želatina rumeni železov oksid (E172)
Medicinal products metabolised by CYP2C19 
Zdravila, ki se presnavljajo s CYP2C19
The secondary endpoint of complete resolution of heartburn, defined as no heartburn on the patient's diary card for 7 consecutive days, was statistically significant at both week 1 (10.0% - 15.2% vs placebo 0.9% - 2.4%, p = 0.014, p<0.001) and week 2 (25.2% - 35.7% vs placebo 3.4% - 9.0%, p<0.001). 
Sekundarni opazovani dogodek, popolno prenehanje zgage, opredeljen kot odsotnost zgage v bolnikovem dnevniku 7 zaporednih dni, je bil statistično pomemben po enem tednu (10,0-15,2 % v primerjavi s placebom 0,9-2,4 %, p = 0,014, p < 0,001) in po 2 tednih (25,2-35,7 % v primerjavi s placebom 3,4-9,0 %, p < 0,001).
Esomeprazole is completely eliminated from plasma between doses with no tendency for accumulation during once-daily administration. 
Esomeprazol se med odmerki povsem odstrani iz plazme in se med uporabo enkrat na dan ne kopiči.
Posology The recommended dose is 20 mg esomeprazole (one tablet) per day. 
Odmerjanje Priporočeni odmerek je 20 mg esomeprazola (ena tableta) na dan.
Alternatively, the tablet can be dispersed in half a glass of non-carbonated water. 
Tablete je možno tudi raztopiti v pol kozarca negazirane vode.
The investigators also found esomeprazole to be significantly more effective than placebo in resolving acid regurgitation (58.5% - 63.6% vs placebo 28.3% - 37.4%) during the week 2 evaluation. 
Med dvotedenskim vrednotenjem so raziskovalci prav tako ugotovili, da je esomeprazol pomembno učinkovitejši od placeba pri prenehanju regurgitacije kisline (58,5-63,6 % v primerjavi s placebom 28,3-37,4 %).
This may cause you symptoms such as a painful sensation in the chest rising up to your throat (heartburn) and a sour taste in the mouth (acid regurgitation). 
Posledica so lahko simptomi, npr. bolečina v prsnem košu, ki se širi proti žrelu (zgaga) ali kisel okus v ustih (vračanje kisline).
Do not take Nexium Control 
Ne jemljite zdravila Nexium Control
Esomeprazole is metabolised by CYP2C19 and CYP3A4. 
Esomeprazol se presnavlja s CYP2C19 in CYP3A4.
Posology The recommended dose is 20 mg esomeprazole (one capsule) per day. 
Odmerjanje Priporočeni odmerek je 20 mg esomeprazola (ena kapsula) na dan.
Nervous system disorders headache dizziness, paraesthesia, somnolence taste disturbance 
Bolezni živčevja glavobol omotica, parestezije, zaspanost motnje okušanja
• If your reflux symptoms get worse or do not improve after taking this medicine for 14 days in a row, you should consult a doctor. 
• Če se vam simptomi refluksa poslabšajo ali ne izboljšajo po jemanju tega zdravila 14 dni zapored, se posvetujte z zdravnikom.
May take 2-3 days for full effect. 
Lahko traja 2-3 dni, preden zdravilo začne popolnoma delovati.
Do not use this medicine after the expiry date which is stated on the carton and the bottle after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali plastenki poleg oznake ''Uporabno do'' ali "EXP".
Both the Rand S-isomer of omeprazole have similar pharmacodynamic activity. 
Farmakodinamično delovanje R- in S-izomera omeprazola je podobno.
cramps, tremor and changes in heart rhythm (arrhythmias). 
tresenje in motnje srčnega ritma (aritmije).
• Dry mouth. 
• suhost ust
• You pass black stools (blood-stained faeces). 
• iztrebljanje črnega (krvavo obarvanega) blata,
• Joint pain (arthralgia) or muscle pain (myalgia). 
• bolečine v sklepih (artralgija) ali mišicah (mialgija)
• Ketoconazole and itraconazole (used to treat infections caused by a fungus). 
• ketokonazol in itrakonazol (uporabljata se za zdravljenje glivičnih okužb)
Co-administration of omeprazole (40 mg once daily) with atazanavir 300 mg/ritonavir 100 mg to healthy volunteers resulted in a substantial reduction in atazanavir exposure (approximately 75% decrease in AUC, Cmax, and Cmin). 
Sočasna uporaba omeprazola (40 mg enkrat na dan) s 300 mg atazanavirja/100 mg ritonavirja je pri zdravih prostovoljcih bistveno zmanjšala izpostavljenost atazanavirju (približno 75 % zmanjšanje AUC, Cmax in Cmin).
• Suddenly feeling wheezy or short of breath (bronchospasm). 
• nenaden pojav piskajočega ali težkega dihanja (bronhospazem)
Treatment with omeprazole 40 mg once a day had no effect on the exposure of lopinavir (with concomitant ritonavir). 
Zdravljenje s 40 mg omeprazola enkrat na dan ni vplivalo na izpostavljenost lopinavirju (sočasno z ritonavirjem).
• The other ingredients are: glycerol monostearate 40-55, hydroxypropylcellulose, hypromellose, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30 per cent, polysorbate 80, sugar spheres (sucrose and maize starch), talc, triethyl citrate, carmine (E120), indigo carmine (E132), titanium dioxide (E171), yellow iron oxide (E172), erythrosine (E127), allura red AC (E129), povidone K-17, propylene glycol, shellac, sodium hydroxide, and gelatin (see section 2, “Nexium Control contains sucrose”.) 
• Druge sestavine zdravila so: glicerilmonostearat 40-55, hidroksipropilceluloza, hipromeloza, magnezijev stearat, metakrilna kislina - etilakrilat, kopolimer (1:1), 30-odstotna disperzija, polisorbat 80, sladkorne kroglice (saharoza in koruzni škrob), smukec, trietilcitrat, karmin (E120), indigo karmin (E132), titanov dioksid (E127), rumeni železov oksid (E172), eritrozin (E127), alura rdeče AC (E129), povidon K-17, propilenglikol, šelak, natrijev hidroksid in želatina (glejte poglavje 2 ''Zdravilo Nexium Control vsebuje saharozo'').
• Tacrolimus (in cases of organ transplantation) 
• takrolimus (uporablja se po presaditvi organov)
Following Overall Treatment Evaluation (OTE) of patients at week 2, 78.0-80.7% of patients on esomeprazole 20 mg, compared to 72.4 - 78.3% for placebo, reported their condition as improved. 
Po skupni oceni zdravljenja po 2 tednih je 78,0-80,7 % bolnikov, ki so dobivali 20 mg esomeprazola, poročalo o izboljšanem stanju v primerjavi z 72,4-78,3 % v skupini s placebom.
14 gastro-resistant capsules. 
14 gastrorezistentnih kapsul
Treatment with omeprazole 20 mg once a day had no effect on the exposure of darunavir (with concomitant ritonavir) and amprenavir (with concomitant ritonavir). 
Zdravljenje z 20 mg omeprazola enkrat na dan ni vplivalo na izpostavljenost darunavirju (sočasno z ritonavirjem) in amprenavirju (sočasno z ritonavirjem).
Gastrointestinal disorders abdominal pain, constipation, diarrhoea, flatulence, nausea/ vomiting, fundic gland polyps (benign) 
Bolezni prebavil bolečine v trebuhu, zaprtost, driska, flatulenca, navzea/bru -hanje, polipi fundičnih žlez (benigni)
An interaction is observed between clopidogrel and esomeprazole. 
Med klopidogrelom in esomeprazolom so ugotovili medsebojno delovanje.
Treatment with esomeprazole 20 mg once a day had no effect on the exposure of amprenavir (with and without concomitant ritonavir). 
Zdravljenje z 20 mg esomeprazola enkrat na dan ni vplivalo na izpostavljenost amprenavirju (sočasno z ritonavirjem ali brez njega).
• They have been on continuous symptomatic treatment of indigestion or heartburn for 4 or more weeks. 
• če se že 4 tedne ali več neprekinjeno simptomatsko zdravijo težave z želodcem ali zgago.
Time to sustained resolution of heartburn, defined as when 7 consecutive days of no heartburn was first recorded, was significantly shorter in the esomeprazole 20 mg group (39.7% - 48.7% by day 14 vs placebo 11.0% - 20.2%). 
Čas do trajnega prenehanja zgage, opredeljen kot 7 zaporednih dni brez zgage od prvega zapisa, je bil pomembno krajši v skupini, ki je dobivala 20 mg esomeprazola (39,7-48,7 % do 14. dneva v primerjavi s placebom 11,0-20,2 %).
If you are overweight or smoke you increase the probability of suffering from heartburn. 
Verjetnost zgage se poveča, če imate prekomerno telesno maso ali kadite.
After five days of oral dosing with 20 mg and 40 mg of esomeprazole, intragastric pH above 4 was maintained for a mean time of 13 hours and 17 hours, respectively over 24 hours in symptomatic gastroesophageal reflux disease (GERD) patients. 
Po petih dneh peroralne uporabe 20 mg esomeprazola pri simptomatskih bolnikih z gastroezofagealno refluksno boleznijo (GERB) je bil želodčni pH nad 4 povprečno 13 ur, po petih dneh peroralne uporabe 40 mg esomeprazola pa povprečno 17 ur v 24 urah.
The capsules should be swallowed whole with half a glass of water. 
Način uporabe Kapsule je treba zaužiti cele s pol kozarca vode.
• Inflammation of the gut (leading to diarrhoea). 
• vnetje v črevesu (ki povzroči drisko)
• An inflammation on the inside of the mouth. 
• vnetje v ustih
If your symptoms worsen or do not improve after taking this medicine for 14 days in a row, contact your doctor. 
Če se znaki vaše bolezni poslabšajo ali ne izboljšajo po jemanju tega zdravila 14 dni zapored, se posvetujte z zdravnikom.
Concomitant administration of esomeprazole has been reported to increase the serum levels of tacrolimus. 
Opisano je, da sočasna uporaba esomeprazola zviša koncentracijo takrolimusa v serumu.
Protease inhibitors 
Zaviralci proteaz
Very rare (may affect up to 1 in 10,000 people) 
Zelo redki (pojavijo se lahko pri največ 1 od 10.000 oseb)
• Methotrexate (used to treat cancer and rheumatic disorders) 
• metotreksat (uporablja se za zdravljenje raka in revmatskih bolezni)
- The other ingredients are glycerol monostearate 40-55, hydroxypropylcellulose, hypromellose, reddish-brown iron oxide (E172), yellow iron oxide (E172), magnesium stearate, methacrylic acid ethylacrylate copolymer (1:1) dispersion 30 per cent, cellulose microcrystalline, synthetic paraffin, macrogol 6000, polysorbate 80, crospovidone (Type A), sodium stearyl fumarate, sugar spheres (sucrose and maize starch), talc, titanium dioxide (E171) and triethyl citrate (see section 2, “Nexium Control contains sucrose”). 
- Druge sestavine zdravila so glicerilmonostearat 40-55, hidroksipropilceluloza, hipromeloza, rdeče rjavi železov oksid (E172), rumeni železov oksid (E172), magnezijev stearat, metakrilna kislina in etilakrilat, kopolimer (1:1), 30-odstotna disperzija, mikrokristalna celuloza, sintetični parafin, makrogol 6000, polisorbat 80, krospovidon (vrsta A), natrijev stearilfumarat, sladkorne kroglice (saharoza in koruzni škrob), smukec, titanov dioksid (E171) in trietilcitrat (glejte poglavje 2 "Zdravilo Nexium Control vsebuje saharozo").
Swallow whole. 
Pogoltnite celo.
The pellets should not be chewed or crushed. 
Zrnc se ne sme žvečiti ali zdrobiti.
Gastro-resistant hard capsule. 
Trda gastrorezistentna kapsula (gastrorezistentna kapsula).
This may cause weakness, being sick (vomiting) and cramps 
To lahko povzroči šibkost, slabost (bruhanje) in krče.
Esomeprazole inhibits CYP2C19, the major esomeprazole metabolising enzyme. 
Esomeprazol zavira CYP2C19, ki je glavni encim za presnovo esomeprazola.
• St. John's wort (Hypericum perforatum) (used to treat depression) 
• šentjanževko (Hypericum perforatum) (uporablja se za zdravljenje depresije)
Co-administration of esomeprazole with atazanavir is not recommended (see section 4.5). 
Sočasna uporaba esomeprazola in atazanavirja ni priporočljiva (glejte poglavje 4.5).
The proportion of patients maintaining an intragastric pH above 4 for at least 8, 12 and 16 hours respectively were for esomeprazole 20 mg 76%, 54%, and 24%. 
Po 20 mg esomeprazola je bil želodčni pH nad 4 vsaj 8 ur pri 76 % bolnikov, vsaj 12 ur pri 54 % bolnikov in vsaj 16 ur pri 24 % bolnikov.
• Severe kidney problems. 
• hude težave z ledvicami
One tablet daily Lasts 24 hours 
Zdravi zgago in refluks želodčne kisline ena tableta na dan deluje 24 ur
Concomitant administration of esomeprazole and a CYP3A4 inhibitor, clarithromycin (500 mg twice a day (b.i.d. 
Sočasna uporaba esomeprazola in zaviralca CYP3A4, klaritromicina (500 mg dvakrat na dan) je podvojila izpostavljenosti (AUC) esomeprazolu.
The tablets should be swallowed whole with half a glass of water. 
Način uporabe Tablete je treba zaužiti cele s pol kozarca vode.
EU/1/13/860/003 14 gastro-resistant capsules 
EU/1/13/860/003 14 gastrorezistentnih kapsul
Skin and subcutaneous tissue disorders dermatitis, pruritus, rash urticaria alopecia, photosensitivity erythema multiforme, StevensJohnson syndrome, toxic epidermal necrolysis (TEN) 
Bolezni kože in podkožja dermatitis, srbenje, izpuščaj, urtikarija alopecija, fotosenzibilnost multiformni eritem,
What Nexium Control contains 
Kaj vsebuje zdravilo Nexium Control
• You are over 55 and have new or recently changed reflux symptoms. 
• ste starejši od 55 let in se vam pojavijo novi simptomi refluksa ali se vam takšni simptomi v zadnjem času spremenijo.
For saquinavir (with concomitant ritonavir), increased serum levels (80-100%) have been reported during concomitant omeprazole treatment (40 mg once a day). 
Med hkratnim zdravljenjem s sakvinavirjem (sočasno z ritonavirjem) in omeprazolom (40 mg enkrat na dan) je bila koncentracija sakvinavirja v serumu večja (80-100 %).
14 gastro-resistant hard capsules 
14 trdih gastrorezistentnih kapsul
Talk to your doctor before taking Nexium Control if: 
Pred začetkom jemanja zdravila Nexium Control se posvetujte z zdravnikom, če:
Adverse reactions such as dizziness and visual disturbances are uncommon (see section 4.8). 
Neželeni učinek omotica se pojavlja občasno, motnje vida pa se pojavljajo redko (glejte poglavje 4.8).
Nexium Control contains sucrose 
Zdravilo Nexium Control vsebuje saharozo
The metabolism of esomeprazole in patients with mild to moderate liver dysfunction may be impaired. 
Presnova esomeprazola je lahko okvarjena pri bolnikih z blagimi do zmernimi motnjami delovanja jeter.
Sodium hydroxide Titanium dioxide (E171) 
Tiskarsko črnilo povidon K-17 propilenglikol šelak natrijev hidroksid titanov dioksid (E171)
It might be necessary to take the tablets for 2-3 consecutive days to achieve improvement of symptoms. 
Za izboljšanje simptomov je morda potrebno jemanje tablet 2 ali 3 dni zapored.
How to take Nexium Control 
Kako jemati zdravilo Nexium Control
• Swallow your tablet whole with half a glass of water. 
• Tableto zaužijte celo s pol kozarca vode.
What Nexium Control looks like and contents of the pack Nexium Control 20 mg gastro-resistant tablets are light pink, oblong, biconvex, 14 mm x 7 mm, filmcoated, engraved with ‘20 mG' on one side and A/EH on the other side. 
Zdravilo Nexium Control 20 mg gastrorezistentne tablete so svetlorožnate, podolgovate, na obeh straneh izbočene (bikonveksne) 14 mm x 7 mm filmsko obložene tablete z vtisnjeno oznako "20 mG" na eni strani in A/EH na drugi strani.
Rare (may affect up to 1 in 1,000 people) 
Redki (pojavijo se lahko pri največ 1 od 1.000 oseb)
If no symptom relief is obtained within 2 weeks of continuous treatment, the patient should be instructed to consult a doctor. 
Bolniku je treba naročiti, da se mora posvetovati z zdravnikom, če po 2 tednih stalnega zdravljenja ni olajšanja simptomov.
Subacute cutaneous lupus erythematosu s (see section 
subakutni kožni eritematozni lupus (glejte poglavje
Esomeprazole is a CYP2C19 inhibitor. 
Esomeprazol zavira CYP2C19.
Esomeprazole is acid labile and is administered orally as enteric-coated granules. 
Esomeprazol je v kislem okolju nestabilen, zato se peroralno uporablja v obliki gastrorezistentnih zrnc.
No gender difference is seen after repeated once-daily administration. 
Po večkratnem odmerjanju enkrat na dan niso ugotovili razlik med spoloma.
• Swallow your capsule whole with half a glass of water. 
• Kapsulo zaužijte celo s pol kozarca vode.
These gastric effects in the rat are the result of sustained, pronounced hypergastrinaemia secondary to reduced production of gastric acid and are observed after long-term treatment in the rat with inhibitors of gastric acid secretion. 
Ti učinki na želodec pri podganah so posledica stalne, izrazite hipergastrinemije zaradi manjšega nastajanja želodčne kisline.
For atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole and concomitant administration is not recommended. 
Ugotovljeno je, da se je koncentracija atazanavirja in nelfinavirja v serumu med sočasno uporabo z omeprazolom zmanjšala, zato takšna sočasna uporaba ni priporočljiva.
It might be necessary to take the capsules for 2-3 consecutive days to achieve improvement of symptoms. 
Za izboljšanje simptomov je morda potrebno jemanje kapsul 2 ali 3 dni zapored.
EU/1/13/860/003 14 gastro-resistant hard capsules 
EU/1/13/860/003 14 trdih gastrorezistentnih kapsul
An increased number of ECL cells possibly related to the increased serum gastrin levels, have been observed in some patients during long-term treatment with esomeprazole. 
Pri nekaterih bolnikih so med dolgotrajnim zdravljenjem z esomeprazolom opažali več enterokromafinim podobnih celic; to je morda posledica večje koncentracije gastrina v serumu.
• When your reflux symptoms have completely gone you should stop taking this medicine. 
• Nehajte jemati to zdravilo, ko simptomi refluksa popolnoma izginejo.
Do not chew, crush or open the capsule. 
Kapsule ne žvečite, drobite ali odpirajte.
Titanium dioxide (E171) 
titanov dioksid (E171) rumeni železov oksid (E172)
• Phenytoin (used to treat epilepsy) 
• fenitoin (uporablja se za zdravljenje epilepsije)
• You get stomach pain or signs of indigestion such as nausea, fullness, bloating especially after food intake. 
občutek polnosti ali napenjanje, zlasti po zaužitju hrane,
Therapeutic monitoring of digoxin should then be reinforced. 
V takšnih okoliščinah je potreben poostreni nadzor koncentracije digoksina v plazmi.
The use of esomeprazole with clopidogrel should be discouraged (see section 4.5). 
Esomeprazola in klopidogrela naj ne bi uporabljali skupaj (glejte poglavje 4.5).
Monitoring is recommended when initiating and ending concomitant esomeprazole treatment during treatment with warfarin or other coumarine derivatives. 
Zato so v primeru zdravljenja z varfarinom ali drugimi kumarinskimi preparati ob uvedbi ali prenehanju sočasne uporabe esomeprazola priporočljive kontrole.
The metabolic rate is decreased in patients with severe liver dysfunction resulting in a doubling of the area under the plasma concentration-time curve of esomeprazole. 
Površina pod krivuljo plazemske koncentracije esomeprazola po času se pri takšnih bolnikih podvoji.
Since the kidney is responsible for the excretion of the metabolites of esomeprazole but not for the elimination of the parent compound, the metabolism of esomeprazole is not expected to be changed in patients with impaired renal function. 
Ledvice so odgovorne za izločanje presnovkov esomeprazola, ne pa za odstranjevanje matičnega zdravila.
• They have had previous gastric ulcer or gastrointestinal surgery. 
• če so kdaj imeli ulkus na želodcu ali operacijo prebavil.
Talk to your doctor as soon as possible if you experience any of the following signs of infection: This medicine may in very rare cases affect the white blood cells leading to immune deficiency. 
To zdravilo lahko v zelo redkih primerih neugodno vpliva na bele krvne celice in povzroči imunsko pomanjkljivost.
Dose adjustment is not required in patients with mild to moderate liver impairment. 
Bolnikom z blago do zmerno okvaro jeter odmerka ni treba prilagoditi.
When given together with PPIs, methotrexate levels have been reported to increase in some patients. 
Pri nekaterih bolnikih so med uporabo skupaj z zaviralci protonske črpalke opazili zvišanje koncentracije metotreksata.
The following adverse reactions have been identified or suspected in the clinical studies programme for esomeprazole and post-marketing. 
V programu kliničnih študij esomeprazola in med uporabo zdravila po prihodu na trg so bili ugotovljeni ali domnevni naslednji neželeni učinki zdravila.
It is recommended to monitor the plasma concentrations of phenytoin when treatment with esomeprazole is introduced or withdrawn. 
Ob uvedbi ali prenehanju zdravljenja z esomeprazolom je priporočljivo spremljati koncentracijo fenitoina v plazmi.
Always take this medicine exactly as described in this leaflet or as your pharmacist has told you. 
Pri jemanju tega zdravila natančno upoštevajte napotke v tem navodilu ali navodila farmacevta.
Each gastro-resistant hard capsule contains 20 mg esomeprazole (as magnesium trihydrate). 
Ena trda gastrorezistentna kapsula vsebuje 20 mg esomeprazola (v obliki magnezijevega trihidrata).
Each gastro-resistant tablet contains 20 mg esomeprazole (as magnesium trihydrate). 
Ena gastrorezistentna tableta vsebuje 20 mg esomeprazola (v obliki magnezijevega trihidrata).
The co-administration of omeprazole (20 mg once a day) with atazanavir 400 mg/ritonavir 100 mg to healthy volunteers resulted in a decrease of approximately 30% in the atazanavir exposure as compared with the exposure observed with atazanavir 300 mg/ritonavir 100 mg once a day without omeprazole 20 mg once a day. 
Sočasna uporaba omeprazola (20 mg enkrat na dan) s 400 mg atazanavirja/100 mg ritonavirja je pri zdravih prostovoljcih zmanjšala izpostavljenost atazanavirju za približno 30 % v primerjavi z izpostavljenostjo ob uporabi 300 mg atazanavirja/100 mg ritonavirja enkrat na dan brez 20 mg omeprazola enkrat na dan. Sočasna uporaba z omeprazolom (40 mg enkrat na dan) je povprečno AUC, Cmax in Cmin nelfinavirja zmanjšala za 36-39 %, povprečno AUC, Cmax in Cmin farmakološko aktivnega presnovka M8 pa za 75-92 %.
Each gastro-resistant capsule contains 20 mg esomeprazole (as magnesium trihydrate). 
Ena gastrorezistentna kapsula vsebuje 20 mg esomeprazola (v obliki magnezijevega trihidrata).
Nexium Control 20 mg gastro-resistant tablets 
Nexium Control 20 mg gastrorezistentne tablete
How to store Nexium Control 
Shranjevanje zdravila Nexium Control
Nexium Control 20 mg gastro-resistant tablets esomeprazole 
Nexium Control 20 mg gastrorezistentne tablete esomeprazol
In these individuals the metabolism of esomeprazole is probably mainly catalysed by CYP3A4. 
Pri slabih metabolizatorjih presnovo esomeprazola verjetno v glavnem katalizira
Nexium Control 20 mg gastro-resistant capsules esomeprazole 
Nexium Control 20 mg gastrorezistentne kapsule esomeprazol